Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$13,046,023
+$1,636,064 QoQ
Shares Held
51,844
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#790
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. ABBV ranks #1 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,046,023 | 51,844 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $11,409,959 | 52,462 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $11,612,773 | 50,824 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $11,644,608 | 50,292 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,931,040 | 53,502 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $11,545,390 | 55,104 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $10,831,169 | 60,952 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $12,159,435 | 61,573 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $10,991,001 | 64,080 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $11,851,795 | 65,084 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,175,018 | 65,658 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,833,934 | 65,973 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $8,727,673 | 64,779 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $10,406,541 | 65,298 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $10,647,027 | 65,881 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $8,911,274 | 66,398 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $10,219,447 | 66,724 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $10,449,933 | 64,462 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $8,578,944 | 63,360 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $7,079,291 | 65,628 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $7,143,178 | 63,416 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,027,373 | 64,936 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $7,240,554 | 67,574 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $6,066,395 | 69,259 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,200,814 | 73,343 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,515,622 | 72,393 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||